The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Clinical Course of Hypertrophic Cardiomyopathy in a Regional United States Cohort
Abstract
CONTEXT: Hypertrophic cardiomyopathy (HCM) has been regarded as a disease that causes substantial disability, with annual mortality rates of up to 6%, based largely on reports from tertiary referral centers. OBJECTIVE: To assess the clinical course of HCM in a patient cohort more closely resembling the true disease state. DESIGN: Retrospective cohort study. SETTING: A regional cohort from Minnesota and adjoining regions, free of referral center bias, studied at Minneapolis Heart Institute. PATIENTS: Two hundred seventy-seven consecutively studied HCM patients, none referred for specialized HCM care, managed clinically in a standard fashion. MAIN OUTCOME MEASURES: Mortality and clinical course of HCM. RESULTS: During a mean (SD) follow-up of 8.1 (6.6) years, 45 patients died and 29 of these deaths were directly related to HCM; however, 8 of the 29 HCM deaths were not premature (occurring >75 years of age). Annual HCM mortality rate was 1.3% (0.7% for sudden cardiac death). Patients identified in adulthood (n = 234) showed no statistically significant difference in mortality when compared with expected mortality, as calculated for the general US or Minnesota populations (P=.17). Patients identified as children (n=43) showed decreased survival compared with the general population (P<.001). At most recent clinical evaluation, 192 patients (69%) had no or mild symptoms and 69 (25%) experienced incapacitating symptoms or HCM-related death; 53 (19%) of the patients had achieved estimated life expectancy of 75 years or older. More advanced symptoms at diagnosis-occurrence of atrial fibrillation (often associated with stroke), the presence of basal outflow obstruction of at least 30 mm Hg, and marked left ventricular wall thickness of more than 25 mm-were clinically important independent predictors of HCM mortality. CONCLUSIONS: In a regionally selected patient population most closely resembling the true disease state, HCM did not significantly increase the risk of premature death or adversely affect overall life expectancy. Prevailing misconceptions of HCM as a generally unfavorable condition may largely be related to the skewed patient referral patterns characteristic of tertiary care centers. Hypertrophic cardiomyopathy is nevertheless a highly complex disease capable of serious clinical consequences and premature death in some patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Management of Hypertrophic Cardiomyopathy
Spirito, P., Seidman, C. E., McKenna, W. J., & Maron, B. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703133361107 · Cited by 1,007
Self-citationKnapp, M. J. (1994) · JAMA · doi:10.1001/jama.271.13.985 · Cited by 1,004
Survival Models and Data Analysis.
Kay, R., Elandt-Johnson, R. C., & Johnson, N. L. (1982) · The Statistician · doi:10.2307/2987637 · Cited by 829
Hypertrophic Cardiomyopathy: Clinical Spectrum and Treatment
Wigle, E. D., Rakowski, H., Kimball, B. P., & Williams, W. G. (1995) · Circulation · doi:10.1161/01.cir.92.7.1680 · Cited by 778
FRANK, S., & BRAUNWALD, E. (1968) · Circulation · doi:10.1161/01.cir.37.5.759 · Cited by 660
Klues, H. G., Schiffers, A., & Maron, B. J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00390-8 · Cited by 656
Self-citationMcKenna, W., Deanfield, J., Faruqui, A., England, D., Oakley, C., & Goodwin, J. (1981) · The American Journal of Cardiology · doi:10.1016/0002-9149(81)90535-x · Cited by 630
Morrow, A. G., Reitz, B. A., Epstein, S. E., Henry, W. L., Conkle, D. M., Itscoitz, S. B., & Redwood, D. R. (1975) · Circulation · doi:10.1161/01.cir.52.1.88 · Cited by 395
Clinical Course and Prognosis of Hypertrophic Cardiomyopathy in an Outpatient Population
Spirito, P., Chiarella, F., Carratino, L., Berisso, M. Z., Bellotti, P., & Vecchio, C. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903233201201 · Cited by 326
Spirito, P., Maron, B. J., Bonow, R. O., & Epstein, S. E. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90998-2 · Cited by 310
Self-citationKnight, C., Kurbaan, A. S., Seggewiss, H., Henein, M., Gunning, M., Harrington, D., Fassbender, D., Gleichmann, U., & Sigwart, U. (1997) · Circulation · doi:10.1161/01.cir.95.8.2075 · Cited by 300
Pacing in hypertrophic obstructive cardiomyopathy: A randomized crossover study
Kappenberger, L., Linde, C., Daubert, C., McKenna, W., Meisel, E., Sadoul, N., Chojnowska, L., Guize, L., Gras, D., Jeanrenaud, X., et al. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015435 · Cited by 298
Cecchi, F., Olivotto, I., Montereggi, A., Santoro, G., Dolara, A., & Maron, B. J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00353-3 · Cited by 296
Self-citationNatural History of Hypertrophic Cardiomyopathy: A Population-Based Study, 1976 Through 1990
Cannan, C. R., Reeder, G. S., Bailey, K. R., Melton, L. J., & Gersh, B. J. (1995) · Circulation · doi:10.1161/01.cir.92.9.2488 · Cited by 264
Predictors of sudden cardiac death in hypertrophic cardiomyopathy
Maki, S., Ikeda, H., Muro, A., Yoshida, N., Shibata, A., Koga, Y., & Imaizumi, T. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00455-x · Cited by 216
Hypertrophic cardiomyopathy: an important cause of sudden death.
McKenna, W. J., & Deanfield, J. E. (1984) · Archives of Disease in Childhood · doi:10.1136/adc.59.10.971 · Cited by 205
PROGNOSIS AND MORTALITY OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
Hardarson, T., Curiel, R., De La Calzada, C. S., & Goodwin, J. F. (1973) · The Lancet · doi:10.1016/s0140-6736(73)92730-x · Cited by 200
The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy.
Shah, P. M., Ag, A., Ed, W., Gobel, F. L., Burchell, H. B., Hardarson, T., Curiel, R. D. J. B., De La Calzada, C., Cm, O., & Goodwin, J. F. (1974) · PubMed · Cited by 199
Panza, J. A., Petrone, R. K., Fananapazir, L., & Maron, B. J. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90057-t · Cited by 198
Self-citationMechanism of Benefit of Negative Inotropes in Obstructive Hypertrophic Cardiomyopathy
Sherrid, M. V., Pearle, G., & Gunsburg, D. Z. (1998) · Circulation · doi:10.1161/01.cir.97.1.41 · Cited by 165
Swan, D. A., Bell, B., Oakley, C. M., & Goodwin, J. F. (1971) · Heart · doi:10.1136/hrt.33.5.671 · Cited by 154
Hypertrophic Cardiomyopathy in Greece
Kyriakidis, M., Triposkiadis, F. K., Anastasakis, A., Theopistou, A. M., Tocta, R., Barbetseas, J. D., & Gialafos, J. H. (1998) · CHEST Journal · doi:10.1378/chest.114.4.1091 · Cited by 129
Maron, B. J., Moller, J. H., Seidman, C. E., Vincent, G. M., Dietz, H. C., Moss, A. J., Towbin, Sondheimer, Pyeritz, McGee, et al. (1998) · PubMed · Cited by 125
Self-citationNatural history of hypertrophic cardiomyopathy in the elderly
Fay, W. P., Taliercio, C. P., Ilstrup, D. M., Tajik, A. J., & Gersh, B. J. (1990) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80328-6 · Cited by 106
Idiopathic hypertrophic subaortic stenosis in the young
Fiddler, G. I., Tajik, A. J., Weidman, W. H., McGoon, D. C., Ritter, D. G., & Giuliani, E. R. (1978) · The American Journal of Cardiology · doi:10.1016/0002-9149(78)90099-1 · Cited by 83
Cited by
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Hypertrophic Cardiomyopathy: A Systematic Review
Maron, B. J. (2002) · JAMA · doi:10.1001/jama.287.10.1308 · Cited by 2,224
“Such data provide a more balanced view in which HCM may be associated with important symptoms and premature death but more frequently with no or relatively mild disability and normal life expectancy.(105,111,113,115,123,124) Elderly HCM patients ( 75 years) have been reported to compose as much as 25% of an HCM cohort…”
BackgroundInfluentialSelf-citationGersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,104
Self-citationZipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Myerburg, R. J., Quinones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,973
Hypertrophic Cardiomyopathy: The Therapeutic Role of Calcium Antagonists
(1982) · Springer eBooks · doi:10.1007/978-3-642-68282-7 · Cited by 1,756
Metadata
- Authors
- Maron, B. J.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1999-02-17
- Volume
- 281
- Issue
- 7
- Pages
- 650
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1989565913
- Cited by
- 554
- References
- 25
- FWCI
- 13.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.